MMP1, matrix metallopeptidase 1, 4312

N. diseases: 589; N. variants: 19
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025202
Disease: melanoma
melanoma
0.100 AlteredExpression disease BEFREE This study revealed an interesting finding that MMP-1 and MMP-13 protein expression in the BRAF V600 mutated melanomas were significantly lower than in the BRAF V600 wild type (P < 0.05). 31677173 2020
CUI: C0025202
Disease: melanoma
melanoma
0.100 GeneticVariation disease BEFREE Our findings highlight the role of BRAF(V600E) in activating the stroma and suggest a mechanistic link between BRAF(V600E) and MMP-1 in mediating melanoma progression and in activating adjacent fibroblasts in the tumour microenvironment. 25117819 2014
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE We report here that Mmp1a is a functional MMP1 homologue that promotes invasion and metastatic progression of mouse lung cancer and melanoma. 22573325 2012
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Together, these studies mechanistically show a previously unrecognized interplay between ERK1/2, TWIST1, and MMP-1 that is likely significant in the progression of melanoma toward metastasis. 23222305 2012
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE As primary tumor thickness and ulceration status are two important indicators of tumor progression and have significant associations with melanoma prognosis, our results suggested that these promoter SNPs in MMP1 might have potential effects on melanoma progression and prognosis by influencing related clinical factors. 22198560 2012
CUI: C0025202
Disease: melanoma
melanoma
0.100 GeneticVariation disease BEFREE These findings suggest that MMP1 promoter polymorphisms may individually or jointly play roles in the development of CM. 20655738 2011
CUI: C0025202
Disease: melanoma
melanoma
0.100 GeneticVariation disease BEFREE We found no strong association between MMP1 variation and the risk of MM or breast cancer. 21642878 2011
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease LHGDN These results show, for the first time, that targeted inhibition of MMP-1, a single effector of the Raf/MEK/ERK signaling cascade, prevents the progression of melanoma from a primary to metastatic tumor and, as such, may represent a useful therapeutic tool in controlling this disease. 18006830 2007
CUI: C0025202
Disease: melanoma
melanoma
0.100 GeneticVariation disease BEFREE In this study, we assessed the functional effects of these polymorphisms on MMP1 gene promoter activity in cell lines of melanoma (A2058 and A375), breast cancer (MCF7 and MDA-MB-231), lung cancer (A549 and H69), and colorectal cancer (HT-29, SW-620) by comparing the promoter strengths of 10 most common haplotypes deriving from these polymorphisms. 17339606 2007
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease LHGDN Thus, these results suggest that MMP-1 produced from melanoma cells would play a role in tumor progression by both degrading matrix proteins and generating active growth factors such as TGF-beta in vivo. 17625450 2007
CUI: C0025202
Disease: melanoma
melanoma
0.100 AlteredExpression disease BEFREE Furthermore, activation of this pathway in transformed melanoma cells (A2058) results in increased expression and activity of MMP-1, MMP-2 and MMP-9, as well as increased invasion using in vitro invasion assays. 15982688 2006
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease LHGDN Taken together, our results indicate an essential role for soluble factors, mainly IL-1alpha and bFGF, in the stimulation of dermal fibroblasts by human melanoma cells to secrete MMP-1. 15737206 2005
CUI: C0025202
Disease: melanoma
melanoma
0.100 AlteredExpression disease BEFREE In this study, we describe four melanoma cell lines that produce high levels of MMP-1 constitutively. 15184373 2004
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease LHGDN Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth. 14962105 2004
CUI: C0025202
Disease: melanoma
melanoma
0.100 AlteredExpression disease BEFREE Basic fibroblast growth factor (bFGF) was detected as an important factor responsible for the enhanced expression of MMP-1 by fibroblasts after stimulation with melanoma cell conditioned medium. 11875642 2002
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Our findings suggest that MMP-1 and -3 may have a special role in melanoma metastasis formation and thus they could be used to measure the biological activity of the disease. 11802203 2002
CUI: C0025202
Disease: melanoma
melanoma
0.100 GeneticVariation disease BEFREE We report here the development of quantitative methods for assessing allelic loss at the MMP-1 locus, and demonstrate that 83% of the metastatic melanomas with loss of heterozygosity at this locus retained the 2G allele. 11159206 2001
CUI: C0025202
Disease: melanoma
melanoma
0.100 GeneticVariation disease BEFREE Of particular interest is a single nucleotide polymorphism in the MMP-1 promoter that increases the transcription of this gene and that is associated with melanoma and with ovarian and endometrial cancers. 11156241 2000
CUI: C0025202
Disease: melanoma
melanoma
0.100 AlteredExpression disease BEFREE Furthermore, MMP-1 mRNA expression and MMP-1 total protein amount in normal fibroblasts were increased by melanoma cell conditioned medium. 10688373 2000
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE For instance, a RAR alpha antagonist suppressed MMP-1 and MMP-2 synthesis in the melanoma cell line, but not in the FaDu or SCC-25 cells. 10415749 1999
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE In the present study we analysed the role of type I collagenase (MMP-1) in melanoma invasion using MIM cells in which the constitutive expression of MMP-1 was suppressed by stable transfection with a plasmid vector expressing a 777 bp antisense fragment of MMP-1 genomic DNA. 9194570 1997
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE A full-length complementary DNA (cDNA) for interstitial collagenase was isolated from an A2058 melanoma cDNA library using the pCD-X Okayama-Berg vector. 2167156 1990